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Polyfluoroalkyl compounds (PFCs) are used 
in the production of fluoropolymers, which 
have applications in protective coatings of 
packaging products, clothes, furniture, and 
nonstick cookware. Some PFCs are persistent 
compounds, ubiquitous in the environment, 
and human exposure is common (Agency for 
Toxic Substances and Disease Registry 2009). 
PFCs have been detected in human sera, breast 
milk, and cord blood (Apelberg et al. 2007; 
Calafat et al. 2007; Karrman et al. 2007).
Exposure to perfluorooctane sulfonate 
(PFOS), perfluorooctanoate (PFOA), and 
perfluorohexane sulfonate (PFHxS)—three 
of the most studied PFCs—may have del-
eterious effects on fetal growth. Lower body 
weights at birth were reported in the offspring 
of rats exposed to PFOS and of mice exposed 
to PFOA during pregnancy (Hines et al. 
2009; Lau et al. 2003, 2006; Luebker et al. 
2005; White et al. 2007; Wolf et al. 2007). 
In humans, maternal serum concentrations of 
PFOS during pregnancy have been inversely 
associated with birth weight (Washino et al. 
2009) and with higher risk of low birth 
weight (Stein et al. 2009), and maternal 
serum concentrations of PFOA have been 
inversely associated with birth weight (Stein 
et al. 2009) and length (Apelberg et al. 2007). 
Cord serum concentrations of both PFOS 
and PFOA were not associated with birth 
weight or length but were inversely associated 
with head circumference and ponderal index 
(Apelberg et al. 2007). However, other stud-
ies did not find associations between maternal 
serum concentrations of PFOS, PFOA, or 
PFHxS and fetal growth in their offspring 
(Hamm et al. 2010; Nolan et al. 2009).
One of the proposed mechanisms by 
which PFCs may affect growth is through acti-
vation of the peroxisome proliferator-activated 
receptor alpha (PPARα) (Abbott et al. 2007). 
The peroxisome proliferator-activated receptor 
(PPAR) family is composed of three isotypes 
(PPARα, β, and γ), which play an important 
role in control of cellular differentiation pro-
grams and in the transcriptional control of 
lipids and carbohydrate metabolism (Casals-
Casas et al. 2008). Mice prenatally exposed 
to PFOA who express the PPARα gene had 
lower postnatal body weights than exposed 
knockout mice that do not express the PPARα 
gene (Abbott et al. 2007). In mice prenatally 
exposed to PFOS, however, postnatal body 
weight was not dependent on PPARα expres-
sion (Abbott et al. 2009). In a separate study, 
higher body weights in midlife were reported 
in female offspring of mice exposed to PFOA 
prenatally (Hines et al. 2009).
Altered development of adipose tissue 
and of the regulatory systems involved in 
body weight homeostasis may explain inverse 
associations of PFOS and PFOA serum con-
centrations with measures of fetal growth 
reported in the epidemiologic literature. The 
influence of prenatal exposures to PFCs on 
weight homeostasis may persist after birth, 
although evidence is limited and somewhat 
inconsistent. The purpose of this investigation 
was to explore associations of maternal serum 
concentrations of PFOA, PFOS, and PFHxS 
during pregnancy with markers of fetal and 
postnatal growth in girls.
Methods
Population. The Avon Longitudinal Study 
of Parents and Children (ALSPAC) enrolled 
pregnant women from three health districts 
of the county of Avon, Great Britain, with 
an expected delivery date between April 1991 
and December 1992. A total of 14,610 chil-
dren joined the cohort at birth. Details of 
recruitment methods are described elsewhere 
(Golding et al. 2001).
In 2004–2005, when enrolled offspring 
were 13 years old, there were 11,820 singleton 
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at birth and at 2, 9, and 20 months. Serum samples were obtained in 1991–1992, from mothers 
during pregnancy. We explored associations between prenatal PFC concentrations and weight at 
birth as well as longitudinal changes in weight-for-age SD scores between birth and 20 months.
results: PFOS (median, 19.6 ng/mL), PFOA (median, 3.7 ng/mL), and PFHxS (median, 
1.6 ng/mL) were detected in 100% of samples. On average, girls born to mothers with prenatal 
concentrations of PFOS in the upper tertile weighed 140 g less [95% confidence interval (CI): 
–238, –42] at birth than girls born to mothers with concentrations in the lower tertile in adjusted 
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95% CI: –206, –10). At 20 months, however, girls born to mothers with prenatal concentrations of 
PFOS in the upper tertile weighed 580 g more (95% CI: 301, 858) when compared with those in the 
lower tertile. No differences in weight were found for PFOA and PFHxS.
conclusions: Girls with higher prenatal exposure to each of the PFCs examined were smaller at 
birth than those with lower exposure. In addition, those with higher exposure to PFOS were larger 
at 20 months.
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active participants in the ALSPAC, of whom 
5,756 (49%) were girls. Of these girls, 3,682 
had returned at least two valid assessments 
of pubertal status between the ages of 8 and 
13 years. We obtained a sample of 448 girls 
from the group of girls with at least two valid 
pubertal assessments for a study of maternal 
serum concentrations of PFCs and menarche 
(Christensen et al. 2011). Cases (n = 218) 
consisted of all the girls who attained menar-
che < 11.5 years, and controls (n = 230) were 
a random sample of noncases who attained 
menarche ≥ 11.5 years of age. We used this 
sample to study associations of maternal expo-
sures to PFCs, estimated from the serum con-
centrations, with fetal and postnatal growth. 
Median age at menarche in the full cohort 
was 12.93 years (Rubin et al. 2009).
Data collection. Birth weight (in grams), 
length (in centimeters), and gestational 
age (in weeks) were abstracted from medi-
cal records. Weight and height at 2 (mean 
± SD = 1.7 ± 0.3), 9 (9.2 ± 0.9), and 20 
(19.7 ± 2.8) months were obtained by health 
professionals as part of the routine infant 
health surveillance program. We converted 
the infant’s weights to weight-for-age SD 
scores (z-scores) using the 1990 British growth 
reference curves for girls (Cole et al. 1995). 
Ponderal index was calculated using the fol-
lowing formula: (weight in grams/length in 
cubic centimeters) × 100. Self-reported data 
on maternal prenatal characteristics and 
behaviors were obtained from the mothers 
during pregnancy. Breast-feeding data were 
obtained from questionnaires administered 
when the girls were 4 weeks old. Data col-
lection instruments and methods have been 
described in detail elsewhere (Golding et al. 
2001). Potential confounders assessed include 
gestational age (weeks); maternal educational 
level (< O level/O level/> O level); maternal 
prepregnancy body mass index (BMI); mater-
nal age at delivery (years); previous live births 
(0/≥ 1); maternal smoking during pregnancy 
(yes/no); mother’s ethnic background (white/
nonwhite); breast-feeding of child between 
birth and 4 weeks (yes/no); and gestational age 
when maternal serum sample was obtained. An 
O-level education is the qualification obtained 
at age 16 years when obligatory schooling 
ends. We assigned maternal prepregnancy 
weight status according to the Centers for 
Disease Control and Prevention (CDC) adult 
BMI classification: underweight (< 18.5), nor-
mal (18.5–24.9), overweight (25.0–29.9), and 
obese (≥ 30.0).
Laboratory analyses. PFOS, PFOA, and 
PFHxS were measured in 448 stored maternal 
serum samples collected during 1991–1992 at 
pregnancy. The median gestational age when 
serum samples were obtained was 15 weeks, 
and the interquartile range was 10–28 weeks. 
Valid results were available for 447 girls. 
Serum samples were analyzed at the National 
Center for Environmental Health of the CDC 
(Atlanta, GA). Analytical methods used have 
been described elsewhere (Kuklenyik et al. 
2005). Limits of detection were 0.2 ng/mL for 
PFOS and 0.1 ng/mL for PFOA and PFHxS. 
We prepared low-concentration (~ 2–9 ng/mL) 
and high-concentration (~ 6–25 ng/mL) qual-
ity control materials with pooled human serum 
that was analyzed with standards, reagent 
blanks, and study samples. Depending on 
the analyte, the precision of measurements, 
expressed as the relative SD, was 8–13%.
Statistical analyses. Our analyses were 
conducted on a sample of girls and their 
mothers previously selected for a nested case–
control study to test associations of PFCs with 
earlier age at menarche. Because ignoring the 
sampling scheme can lead to biased results, we 
accounted for sampling selection probabilities 
by constructing stratum-weighted linear and 
longitudinal regression models to estimate the 
associations between PFC concentrations and 
fetal and postnatal growth (Richardson et al. 
2007). The weight for the cases (all girls who 
attained menarche < 11.5 years) was 1, and 
the weight for the controls (a random sample 
of girls who attained menarche ≥ 11.5 years of 
age) was 15.1.
The markers of fetal growth studied were 
birth weight, birth length, gestational age, 
and ponderal index. We constructed stratum-
weighted adjusted linear regression models 
to explore associations of each birth outcome 
with maternal serum concentrations of PFOA, 
PFOS, and PFHxS. We used the same lin-
ear regression methods to model outcomes 
at 20 months. The single-pollutant stratum-
weighted models for each study outcome were 
constructed using backward elimination to 
identify potential confounders, with p < 0.20 
as the cutoff for retention. Trend tests for 
analyses of associations with outcomes at 
birth and at 20 months were done where the 
exposure was modeled as an ordinal variable 
and coded as 0, 1, and 2. We tested whether 
exposure–response trends were significantly 
different from the null using a p < 0.05.
We examined the influence of miss-
ing values for covariates missing values for 
≥ 10% of girls. The covariates missing values 
in this range were maternal smoking during 
pregnancy and maternal prepregnancy BMI. 
Comparisons of bivariate associations between 
the exposures and study outcomes before and 
after exclusion of girls missing data on either 
maternal prepregnancy BMI or smoking dur-
ing pregnancy were conducted to verify for 
consistency. Results of such analyses sug-
gested that exclusion of subjects missing val-
ues for theses covariates had the potential to 
introduce bias because changes in the mag-
nitude and direction of bivariate associations 
were observed after these exclusions. Because 
maternal smoking and maternal pre-pregnancy 
BMI are predictors of the daughter’s growth, 
categories for missing values were included in 
the analyses of fetal and postnatal growth.
Linear mixed models were used for the 
longitudinal analyses of weight (Verbeke and 
Molenberghs 1997). We included girls who 
had 3 or 4 weight-for-age SD scores using 
weights obtained at birth or 2, 9, or 20 
months (n = 410). The “time” variable repre-
sents the month of age when weight measure-
ments were taken. These models were also 
constructed with sampling weights to account 
for the nested case–control sampling.
First, we created exploratory graphs to 
observe weight-for-age patterns over time by 
exposure and potential predictors (maternal 
prepregnancy BMI, maternal age at deliv-
ery, maternal educational level, previous live 
births, maternal smoking during pregnancy, 
gestational age, gestational age when maternal 
serum sample was obtained, and breast-feeding 
in the first 4 weeks). Weight-for-age patterns 
between 2 and 20 months appeared to be qua-
dratic rather than linear. As described previ-
ously, a category for missing data was included 
for maternal smoking during pregnancy and 
maternal prepregnancy BMI. Then we fit satu-
rated linear mixed-effects models for each of 
the three PFC exposures (exposures catego-
rized as tertiles), and included intercept, age, 
and age-squared parameters for the exposures 
and potential predictors. To assess whether 
exposures or predictors influenced weight pat-
terns, we included interactions between age 
and each covariate and age-squared and each 
covariate. We used the saturated model to test 
for random-effects and various random-effects 
covariance structures. It was appropriate to 
include a random intercept in addition to ran-
dom slopes (for age and age-squared), with an 
unstructured random-effects covariance struc-
ture. We removed covariates in a hierarchical 
way, using backward elimination, to obtain 
a reduced model. The exposure was retained 
regardless of significance. Nested models 
were compared with likelihood ratio tests and 
potential predictors that were significant at the 
p < 0.20 were retained. Finally, we constructed 
graphs to depict the predicted mean weight-
for-age SD scores, based on the final linear 
mixed-effects models, which were calculated 
at the 4 time points (birth and 2, 9 and 20 
months), with PFC exposure as tertiles and all 
other covariates at their reference. All analyses 
were conducted using SAS version 9.2 (SAS 
Institute Inc., Cary, NC). Analyses of mark-
ers of fetal growth were performed in PROC 
GLM and the longitudinal mixed models were 
performed in PROC MIXED.
Human subject protection was assessed 
and approved by the ALSPAC Law and Ethics 
Committee, the local research ethics commit-
tees, and the CDC Institutional Review Board.
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Informed consent was provided by the 
mothers at the time of enrollment. The 
daughters did not provide consent as such 
because they were children.
Results
Analytes were detected in 100% of samples. 
PFOS showed the highest median maternal 
serum concentrations followed by PFOA, and 
PFHxS respectively (Table 1). Spearman cor-
relation coefficients showed a high level of cor-
relation between PFOS and PFOA (r = 0.72) 
and moderate to high levels between PFHxS 
and PFOS (r = 0.54) and PFHxS and PFOA 
(r = 0.44).
Among the 447 girls mean birth weight 
(± SD) was 3,397 ± 449 g; birth length 
was 50.4 ± 2.2 cm; ponderal index was 
2.7 ± 0.2 kg/m3; and gestational age was 
39.8 ± 1.6 weeks. Fewer than 4% of girls were 
preterm or born weighing < 2,500 g. About 
half of the mothers reported a normal mater-
nal prepregnancy BMI and having had at least 
one previous live birth. Most mothers were 
white (95%) (Table 1).
Sample sizes for multivariate analyses var-
ied from 320 to 395 in the main analyses and 
from 106 to 107 in stratified analyses. On 
average, girls born to mothers with mater-
nal serum concentrations of PFOS in the 
upper tertile weighed 140 g [95% confidence 
interval (CI): –238, –42] less at birth com-
pared with girls born to mothers with serum 
concentrations in the lower tertile in models 
adjusted for gestational age, maternal prepreg-
nancy BMI, previous live births, and maternal 
smoking during pregnancy (Table 2). Girls 
born to mothers with maternal serum con-
centrations of PFOS in the middle tertile also 
weighed less at birth, on average, than did 
girls born to mothers with serum concentra-
tions in the lower tertile. Similar magnitudes 
of weight differences were observed between 
girls whose mothers had the highest and low-
est serum concentrations of PFOA (–133 g; 
95% CI: –237, 30) and PFHxS (–108 g; 95% 
CI: –206, –10). Results for associations of 
birth length with PFOS and PFHxS showed 
similar patterns to those observed for birth 
weight in models adjusted for gestational age, 
maternal educational level, maternal prepreg-
nancy BMI, previous live births, and maternal 
smoking during pregnancy. Trend tests sug-
gest exposure–response gradients across tertiles 
of maternal serum concentrations of the three 
PFCs tested for birth weight and across tertiles 
of PFOS and PFHxS but not PFOA for birth 
length. Results for gestational age and pon-
deral index did not suggest an association with 
the PFCs tested (Table 2).
Pearson correlation coefficients showed 
strong correlations between birth weight and 
weight at 20 months (r = 0.32; p < 0.0001; 
n = 339), birth weight and height at 20 months 
(r = 0.20; p < 0.0003; n = 339), and weight at 
20 months and height at 20 months (r = 0.67; 
p < 0.0001; n = 343). In adjusted analyses 
of weight at 20 months, when either birth 
weight or height at 20 months or both were 
included in the model, girls with the highest 
maternal serum concentrations were on aver-
age between 438 and 580 g heavier than girls 
with maternal serum concentrations in the 
lower tertile (Table 3). Weight at 20 months 
was not associated with the other PFCs.
To better understand the role of birth 
weight in the association between weight at 
20 months and exposure to PFOS, we further 
stratified weight at 20 months by birth weight 
and tertiles of exposure (Table 4). Among girls 
in the upper birth weight stratum, the highest 
serum maternal concentrations of PFOS were 
on average 600 g (95% CI: –53, 1,245) heavier 
at 20 months than those with the lowest serum 
concentrations. Among girls in the middle 
birth weight stratum, we did not find weight at 
20 month to be associated with PFOS. Finally, 
among girls in the lowest birth weight stratum 
those with the highest maternal serum con-
centrations of PFOS where on average 933 g 
(95% CI: 187, 1,679) heavier than those with 
the lowest serum concentrations.
Figure 1 gives the predicted mean weight-
for-age SD scores by PFC exposure tertiles 
(predicted at birth and 2, 9, and 20 months) 
based on the longitudinal mixed models. The 
corresponding coefficients from the mixed 
models are provided in Supplemental Material, 
Table S1 (http://dx.doi.org/10.1289/
ehp.1003096). The initial points on the 
Table 1. Frequency distribution and maternal serum concentrations (in ng/mL) in 1991–1992 for selected 









Overall 447 (99.7) 19.6 (3.8–112.0) 3.7 (1.0–16.4) 1.6 (0.2–54.8)
Maternal prepregnancy BMI
Underweight 18 (4.03) 16.9 (11.1–42.9) 3.5 (1.2–8.3) 1.5 (0.7–3.6)
Normal 290 (64.88) 20.1 (3.8–112.0) 3.8 (1.0–15.7) 1.6 (0.2–54.1)
Overweight 62 (13.87) 20.9 (11.3–47.6) 3.7 (1.9–6.5) 1.9 (0.7–17.5)
Obese 31 (6.94) 19.2 (9.4–74.2) 3.6 (2.1–11.1) 1.4 (0.9–4.4)
Missinga 46 (10.29) 17.3 (8.5–94.5) 3.5 (1.3–16.4) 1.6 (0.5–54.8)
Maternal age at delivery (years)
< 25 92 (20.58) 18.5 (9.2–32.6) 3.9 (1.8–8.6) 1.6 (0.8–6.2)
25–29 164 (36.69) 20.7 (6.5–112) 3.8 (1.2–16.4) 1.6 (0.6–54.8)
≥ 30 188 (42.06) 19.6 (3.8–74.2) 3.6 (1.0–15.7) 1.7 (0.2–49.8)
Missing 3 (0.67)
Maternal education
< O level 89 (19.91) 8.2 (8.94.5) 3.6 (1.3–16.4) 6 (0.4–54.8)
O level 140 (31.32) 19.6 (8.5–112.0) 3.7 (1.6–8.6) 1.6 (0.5–37.3)
> O level 199 (44.52) 20.4 (3.8–69.2) 3.9 (1.0–15.7) 1.7 (0.2–54.1)
Missing 19 (4.25)
Maternal race
White 422 (94.41) 19.9 (6.5–112.0) 3.8 (1.1–16.4) 1.6 (0.2–54.8)
Nonwhite 8 (1.79) 14.6 (3.8–25.6) 2.3 (1.0–3.5) 1.4 (0.3–2.8)
Missing 17 (3.80)
Previous live births
0 212 (47.43) 21.5 (6.5–94.5) 4.4 (1.5–16.4) 1.8 (0.4–54.8)
≥ 1 215 (48.10) 18.2 (3.8–74.2) 3.1 (1.0–13.8) 1.5 (0.2–49.8)
Missing 20 (4.47)
Smoking during pregnancy
Yes 85 (19.02) 17.2 (7.6–39.6) 3.4 (1.2–7.5) 1.6 (0.2–9.5)
No 318 (71.14) 20.9 (4.3–112.0) 3.9 (1.0–16.4) 1.7 (0.3–54.8)
Missinga 44 (9.84) 18.0 (3.8–74.2) 3.2 (1.1–11.1) 1.4 (0.4–24.9)
Low birth weight
Yes 17 (3.80) 21.8 (4.3–112.0) 4.1 (1.0–11.1) 1.7 (0.3–37.3)
No 422 (94.41) 19.6 (3.8–94.5) 3.7 (1.1–16.4) 1.6 (0.2–54.8)
Missing 8 (1.79)
Preterm delivery
Yes 14 (3.13) 23.9 (10.9–112.0) 4.7 (2.5–8.5) 1.7 (0.9–37.3)
No 430 (96.20) 19.6 (3.8–94.5) 3.7 (1.0–16.4) 1.6 (0.2–54.8)
Missing 3 (0.67)
Breast-feeding in first 4 weeks
Yes 358 (80.09) 19.9 (3.8–112.0) 3.7 (1.0–16.4) 1.6 (0.2–54.8)
No 74 (16.55) 18.2 (8.5–39.6) 3.7 (2.1–6.7) 1.7 (0.6–7.1)
Missing 15 (3.36)
Menarche (years)
< 11.5 218 (48.77) 19.5 (3.8–112.0) 3.9 (1.0–15.7) 1.7 (0.3–7.3)
> 11.5 229 (51.23) 19.9 (7.6–94.5) 3.6 (1.1–16.4) 1.6 (0.2–54.8)
Abbreviations: max, maximum; min, minimum.
aCategory for missing values was included in the analyses.
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Table 2. Adjusted least square means (LSM) and regression coefficients (β) for prenatal growth measures by tertiles of PFOS, PFOA, and PFHxS in a sample of 
British girls in 1991–1992.
Tertiles of 
analyte (ng/mL)
Birth weighta (g) (n = 422) Birth lengthb (cm) (n = 356) Gestational agec (weeks) (n = 444) Ponderal indexd (n = 360)
LSM β (95% CI) LSM β (95% CI) LSM β (95% CI) LSM β (95% CI)
PFOS
< 16.6 3438.59 Reference 50.91 Reference 39.84 Reference 2.66 Reference
16.6–23.0 3326.88 –111.71 (–208.24, –15.17) 50.19 –0.72 (–1.19, –0.25) 39.82 –0.02 (–0.39, 0.35) 2.66 –0.00 (–0.07, 0.06)
> 23.0 3298.57 –140.01 (–238.14, –41.89) 50.28 –0.63 (–1.11, –0.15) 39.69 –0.15 (–0.53, 0.23) 2.71 0.05 (–0.01, 0.12)
Trend test p-value 0.0053 0.0103 0.4352 0.1120
PFOA
< 3.1 3419.22 Reference 50.54 Reference 39.96 Reference 2.69 Reference
3.1–4.4 3362.41 –56.81 (–153.05, 39.43) 50.67 0.14 (–0.34, 0.61) 39.72 –0.25 (–0.61, 0.12) 2.63 –0.06 (–0.12, 0.01)
> 4.4 3285.77 –133.45 (–237.37, –29.54) 50.10 –0.44 (–0.96, 0.08) 39.62 –0.34 (–0.73, 0.05) 2.71 0.02 (–0.05, 0.09)
Trend test p-value 0.0120 0.0978 0.0833 0.5920
PFHxS
< 1.3 3402.21 Reference 50.93 Reference 39.91 Reference 2.67 Reference
1.3–2.0 3393.10 –9.10 (–108.08, 89.88) 50.41 –0.52 (–1.00, –0.04) 39.76 –0.15 (–0.52, 0.22) 2.70 0.03 (–0.04, 0.09)
> 2.0 3294.27 –107.93 (–206.18, –9.69) 50.11 –0.82 (–1.29, –0.34) 39.67 –0.24 (–0.62, 0.14) 2.65 –0.01 (–0.08, 0.05)
Trend test p-value 0.0314 0.0008 0.2170 0.6802
For maternal prepregnancy BMI and smoking during pregnancy, categories for missing values were included in the analyses. 
aAdjusted by maternal smoking during pregnancy, maternal prepregnancy BMI, previous live births, and gestational age. bAdjusted by maternal smoking during pregnancy, maternal 
prepregnancy BMI, maternal education, previous live births, and gestational age. cAdjusted by gestational age when maternal serum sample was obtained. dAdjusted by maternal 
prepregnancy BMI, previous live births, and gestational age when maternal serum sample was obtained. 
Table 3. Adjusted least square means (LSM) and regression coefficients (β) for weight (g) at 20 months by tertiles of PFOS, PFOA, and PFHxS in a sample of 
British girls in 1991–1992.
Tertiles of  
analyte (ng/mL)
Weight at 20 monthsa (g)  
(n = 324)
Weight at 20 months (g)  
adjusted by birth weighta  
(n = 320)
Weight at 20 months (g)  
adjusted by height at 20 monthsa  
(n = 324)
Weight at 20 months (g) 
adjusted by height at 20 months  
and birth weighta (n = 320)
LSM β (95% CI) LSM β (95% CI) LSM β (95% CI) LSM β (95% CI)
PFOS
< 16.6 11412.6 Reference 11418.9 Reference 11363.9 Reference 11360.1 Reference
16.6–23.0 11513.6 100.93 (–282.81, 484.68) 11529.4 110.4 (–262.70, 483.60) 11678.5 314.60 (19.37, 609.82) 11670.7 310.64 (27.19, 594.08)
> 23.0 11777.0 364.35 (–15.14, 743.83) 11857.4 438.4 (71.09, 805.65) 11863.7 499.84 (208.67, 791.01) 11939.9 579.82 (301.40, 858.25)
Trend test p-value 0.0598 0.0195 0.0008 < 0.0001
PFOA
< 3.1 11635.0 Reference 11597.0 Reference 11737.2 Reference 11695.3 Reference
3.1–4.4 11460.7 –174.31 (–550.55, 201.94) 11512.3 –84.75 (–452.58, 283.08) 11477.0 –260.24 (–550.48, 30.00) 11511.1 –184.21 (–465.90, 97.48)
> 4.4 11644.5 9.48 (–405.48, 424.44) 11739.3 142.31 (–262.06, 546.67) 11752.1 14.93 (–304.92, 334.783) 11823.7 128.40 (–180.94, 437.74)
Trend test p-value 0.9642 0.4892 0.9269 0.4147
PFHxS
< 1.3 11566.2 Reference 11531.2 Reference 11664.8 Reference 11624.9 Reference
1.3–2.0 11534.4 –31.84 (–416.87, 353.20) 11558.8 27.58 (–346.32, 401.49) 11632.0 –32.83 (–331.30, 265.65) 11637.3 12.33 (–275.56, 300.22)
> 2.0 11629.1 62.86 (–326.68, 452.40) 11739.6 208.43 (–170.60, 587.46) 11652.3 –12.55 (–314.69, 289.58) 11740.4 115.40 (–176.69, 407.50)
Trend test p-value 0.7511 0.2801 0.9349 0.4375
aValues were also adjusted by maternal education, maternal age at delivery, and previous live birth. 
Table 4. Adjusted least square means (LSM) and regression coefficients (β) for weight at 20 months stratified by tertiles of PFOS, PFOA, and PFHxS and tertiles 
of birth weighta in a sample of British girls in 1991–1992.
Upper tertile > 3,580 g  
(n = 106)
Middle tertile 3,200–3,580 g  
(n = 107)
Lower tertile < 3,200 g  
(n = 107)
LSM β (95% CI) LSM β (95% CI) LSM β (95% CI)
PFOS
< 16.6 11577.29 Reference 11659.86 Reference 10827.14 Reference
16.6–23.0 11910.86 333.57 (–301.28, 968.42) 11397.04 –262.83 (–884.25, 358.60) 11429.78 602.64 (–150.79, 1356.07)
> 23.0 12173.51 596.22 (–52.98, 1245.42) 11825.29 165.43 (–439.52, 770.37) 11759.85 932.71 (186.90, 1678.52)
Trend test p-value 0.0714 0.5886 0.0148
PFOA
< 3.1 11906.83 Reference 11598.90 Reference 11259.57 Reference
3.1–4.4 11921.96 15.13 (–573.62, 603.87) 11477.35 –121.55 (–708.11, 465.01) 11238.43 –21.13 (–827.99, 785.72)
> 4.4 11879.43 –27.39 (–785.40, 730.61) 11768.73 169.83 (–497.87, 837.54) 11507.84 248.27 (–570.54, 1067.08)
Trend test p-value 0.9430 0.6149 0.5488
PFHxS
< 1.3 11854.12 Reference 11738.45 Reference 11003.43 Reference
1.3–2.0 11782.43 –71.69 (–668.06, 524.68) 11511.75 –226.70 (–847.25, 393.84) 11326.72 323.28 (–453.95, 1100.51)
> 2.0 12159.19 305.07 (–404.41, 1014.54) 11687.39 –51.07 (–666.53, 564.40) 11601.69 598.26 (–166.91, 1363.43)
Trend test p-value 0.3955 0.8696 0.1240
aAdjusted by maternal education, maternal age at delivery, previous live birth, and birth weight as a continuous variable. 
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figures represent the intercept coefficients for 
weight at birth. The estimates for the intercept 
coefficients were consistent with the analy-
ses of PFC exposures with birth weight: Girls 
in the upper tertile of exposure weighed less 
than the girls in the lower tertile. Girls in the 
middle tertile weighed less than girls in the 
lower tertile. However, the p-values for the 
differences between the intercept coefficients 
did not reach statistical significance (PFOS, 
p = 0.28; PFOA, p = 0.27; PFHxS, p = 0.21).
The remaining points on Figure 1 repre-
sent predicted mean weight-for-age SD scores 
by PFC exposure for 2, 9, and 20 months. 
For girls in the lowest tertile of exposure to 
PFOS, there is very little change in weight-
for-age SD score over time (they remain 
around the median weight-for-age at each 
time point). However, the trajectory for girls 
in the middle and upper exposure tertiles 
surpass the lower tertile group by 9 months. 
Further, the girls in the middle- and upper-
tertile groups remain heavier at 20 months 
than the girls in the lower tertile group. For 
the PFOA and the PFHxS figures, the tra-
jectory of weight-for-age SD scores follow a 
more similar pattern for the girls in the lower 
and middle exposure tertile groups, whereas 
by 9 months the girls in the upper tertile 
groups exceed (for PFOA) or reach (PFHxS) 
the weight of the girls in the lower and middle 
tertile groups. Although the figure suggests 
that the weight-for-age trajectories appear to 
vary to some extent by exposure tertiles over 
time, interaction term coefficients for time 
and tertiles of exposure from the mixed mod-
els were not statistically significant (p > 0.05) 
[see Supplemental Material, Table S1 (http://
dx.doi.org/10.1289/ehp.1003096)].
As in the single time point analyses of 
weight at 20 months, we were interested in 
understanding the role of birth weight in the 
weight-for-age SD patterns between 2 and 
20 months. To do so, we removed birth weight 
as a time point in the longitudinal analyses and 
reran the mixed models with three time points 
(2, 9, and 20 months), and stratified by birth 
weight (data not shown). In these models, for 
the intercept we found that within the lower 
birth weight strata, girls were smaller at birth 
in the higher-exposure tertile than those in the 
lower-exposure tertile. This was also seen for 
the upper birth weight strata. The coefficients 
for girls in the middle birth weight group were 
larger with higher PFC concentrations. The 
time trend coefficients followed a similar pat-
tern for the girls in the lower and upper birth 
weight groups, compared with the middle birth 
weight group.
Discussion
Evidence from animal and human studies 
suggests that prenatal exposures to PFCs may 
have deleterious effects on fetal and postnatal 
growth. We explored associations of maternal 
serum concentrations of PFOS, PFOA, and 
PFHxS during pregnancy with markers of fetal 
and postnatal growth in a sample of British 
girls. In our study we found that girls born to 
mothers with higher serum PFC concentrations 
during pregnancy were smaller at birth. The 
magnitude of the differences in birth weight 
and length by tertile was similar across all the 
PFCs evaluated, and an  exposure–response gra-
dient was observed. Girls with higher prenatal 
concentrations of the PFC also appear to be 
heavier at 20 months.
The PFCs most commonly assessed in 
other epidemiologic studies of fetal growth 
were PFOA and PFOS. Our results are con-
sistent with those reported by others, although 
the magnitude of the differences in birth 
weight and length are not strictly comparable 
between studies because of differences in ana-
lytical strategy or biological media where PFCs 
were assessed (Apelberg et al. 2007; Arbuckle 
et al. 2012; Washino et al. 2009). Two studies 
looked at PFHxS and birth weight (Arbuckle 
et al. 2012; Hamm et al. 2010). Although 
both found no association, exposure levels 
were quite low, with a large proportion of 
samples without detectable PFHxS. Maternal 
serum concentrations of PFOS, PFOA, and 
PFHxS in our study were higher than those 
reported in other population-based studies of 
fetal growth conducted in Japan (Washino 
et al. 2009), Canada (Hamm et al. 2010), and 
the United States (Apelberg et al. 2007) but 
lower than those reported in a Danish study 
(Fei et al. 2008, 2007). Except for the Danish 
study, where serum sample collection began in 
1996, sample collection in other studies began 
after the year 2000. Maternal serum samples 
in our study were collected in the early 1990s, 
when worldwide production rates of PFOS, 
PFOA, and presumably PFHxS were greater 
than current rates. The higher maternal con-
centrations of PFCs in our study may explain, 
in part, the consistency of our associations 
across the PFCs evaluated. The observed shift 
in birth weight distribution in association with 
in utero PFC exposure is smaller than those 
reported for maternal smoking. However, 
because PFCs are ubiquitous in the environ-
ment, human exposure is common and, for 
the most part, involuntary, altered prenatal 
growth due to PFC exposure may represent an 
important public health issue.
The greatest variations in rates of weight 
gain are usually seen in the first 2 years of life, 
when infants show accelerated or diminished 
growth to compensate for intrauterine restraint 
or enhancement of fetal growth (Ong et al. 
2000). In our analyses, we found that girls 
with higher prenatal exposures to the PFCs 
examined were smaller at birth and heavier at 
20 months. A recently published study found 
that in utero exposure to PFOA, but not PFOS, 
was positively associated with BMI and weight 
circumference at 20 years in females, suggesting 
that obesity could be associated with gestational 
PFC exposures (Halldorsson et al. 2012).
Relationships between the PFCs and pat-
terns in weight-for-age SD scores between 
birth and 20 months described by plotting 
predicted means from longitudinal models 
were not linear. Adiposity increases in the 
first year of life and subsequently decreases 
(Rolland-Cachera et al. 1987). We have previ-
ously reported an adiposity decrease after the 
first year of life in ALSPAC girls (Maisonet 
et al. 2010). This decrease suggests a slower 
pace of weight gain between 9 and 20 months 
compared with the period between birth and 
9 months in ALSPAC girls. In our study, age 
points when postnatal weight and height data 
were obtained were not established a priori but 
determined by the available data.
Our analysis was conducted on a sample 
of girls and their mothers selected for a nested 
Figure 1. Predicted means for weight-for-age SD scores by age in months and tertiles of maternal serum concentrations of PFOS (A), PFOA (B), and PFHxS (C) 
from mixed models, adjusted by previous live birth and maternal smoking during pregnancy. For maternal smoking during pregnancy, a category for missing 
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case–control study of pubertal development. 
For this reason we used weighted regression 
models to estimate the associations between 
PFC maternal serum concentrations and fetal 
and postnatal growth to adjust for the sam-
pling scheme. Our results could be biased 
if girls with missing data (excluded from 
analysis) were different from girls who were 
included in these analyses. Mean values of the 
study outcomes and maternal characteristics 
for girls included in final multivariate analyses 
were similar to the group of girls enrolled in 
the cohort (~ 3,000), suggesting that selection 
bias is an unlikely explanation for our results. 
Finally, although we were unable to exam-
ine postnatal exposure to PFCs and impact 
on postnatal growth in this study, this is an 
important question for future research.
Conclusion
Girls born to mothers with higher serum con-
centrations of PFOS, PFOA, and PFHxS dur-
ing pregnancy appear to be smaller at birth 
and heavier at 20 months.
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